Summary of single cell analysis of HRS-like and B-CLL cells
Pt. . | Cell Type . | V Gene . | No. of Positive Samples/Total No. . | PCR Products . | Repeated Rearrangements . | |
---|---|---|---|---|---|---|
Total . | Sequenced . | |||||
1 | HRS-like | VH | 13/43 | 13 | 13 | 13 VH4 (DP63)3-150 |
Vκ | 0/22 | |||||
Vλ | 7/28 | 7 | 7 | 2 Vλ3 (3r) | ||
5 Vλ3 (3a) | ||||||
B-CLL | VH | 24/57 | 24 | 15 | 15 VH4 (DP63) | |
Vκ | 0/22 | |||||
Vλ | 19/40 | 19 | 10 | 7 Vλ3 (3r) | ||
3 Vλ3 (3a) | ||||||
T cells | 1/25 | 1 | 1 | 1 VH4 (DP63)3-151 | ||
Buffer | 0/13 | |||||
2 | HRS-like | VH | 10/33 | 10 | 10 | 10 VH3 (V3-30) |
Vκ | 0/5 | |||||
Vλ | 3/28 | 3 | 3 | 3 Vλ3 (GLL150) | ||
B-CLL | VH | 7/36 | 7 | 7 | 7 VH3 (hv3005) | |
Vκ | 2/12 | 4 | 3 | 1 Vκ2 (O1/O11) | ||
2 Vκ3 (L2) | ||||||
Vλ | 2/24 | 2 | 2 | 2 Vλ3 (lv318) | ||
T cells | 0/18 | |||||
Buffer | 0/13 | |||||
3 | HRS-like | VH | 4/16 | 4 | 43-152 | 3 VH4 (VH4.16) |
Vλ | 4/16 | 4 | 4 | 4 Vλ1 (1c-1) | ||
B-CLL | VH | 5/16 | 10 | 9 | 4 VH3 (V3-23) | |
5 VH3 (DP48) | ||||||
Vλ | 4/16 | 4 | 4 | 4 Vλ1 (1c-2) | ||
T cells | 1/5 | 3 | 3 | 1 VH3 (V3-23) | ||
1 VH3 (DP48) | ||||||
1 Vλ1 (1c-2) | ||||||
Buffer | 2/10 | 2 | 2 | 2 VH3 (V3-23) |
Pt. . | Cell Type . | V Gene . | No. of Positive Samples/Total No. . | PCR Products . | Repeated Rearrangements . | |
---|---|---|---|---|---|---|
Total . | Sequenced . | |||||
1 | HRS-like | VH | 13/43 | 13 | 13 | 13 VH4 (DP63)3-150 |
Vκ | 0/22 | |||||
Vλ | 7/28 | 7 | 7 | 2 Vλ3 (3r) | ||
5 Vλ3 (3a) | ||||||
B-CLL | VH | 24/57 | 24 | 15 | 15 VH4 (DP63) | |
Vκ | 0/22 | |||||
Vλ | 19/40 | 19 | 10 | 7 Vλ3 (3r) | ||
3 Vλ3 (3a) | ||||||
T cells | 1/25 | 1 | 1 | 1 VH4 (DP63)3-151 | ||
Buffer | 0/13 | |||||
2 | HRS-like | VH | 10/33 | 10 | 10 | 10 VH3 (V3-30) |
Vκ | 0/5 | |||||
Vλ | 3/28 | 3 | 3 | 3 Vλ3 (GLL150) | ||
B-CLL | VH | 7/36 | 7 | 7 | 7 VH3 (hv3005) | |
Vκ | 2/12 | 4 | 3 | 1 Vκ2 (O1/O11) | ||
2 Vκ3 (L2) | ||||||
Vλ | 2/24 | 2 | 2 | 2 Vλ3 (lv318) | ||
T cells | 0/18 | |||||
Buffer | 0/13 | |||||
3 | HRS-like | VH | 4/16 | 4 | 43-152 | 3 VH4 (VH4.16) |
Vλ | 4/16 | 4 | 4 | 4 Vλ1 (1c-1) | ||
B-CLL | VH | 5/16 | 10 | 9 | 4 VH3 (V3-23) | |
5 VH3 (DP48) | ||||||
Vλ | 4/16 | 4 | 4 | 4 Vλ1 (1c-2) | ||
T cells | 1/5 | 3 | 3 | 1 VH3 (V3-23) | ||
1 VH3 (DP48) | ||||||
1 Vλ1 (1c-2) | ||||||
Buffer | 2/10 | 2 | 2 | 2 VH3 (V3-23) |
HRS-like and B-CLL cells were analyzed together with T cells, and the controls were aspirated samples of the buffer covering the tissue sections during the micromanipulation. The data on patient 1 represent a summary of three independent micromanipulation experiments, and one repeat experiment was performed for patient 2. The clonalVH and Vγ genes from HRS-like cells were coamplified in one cell from patient 1 (VH4 and Vλ3gene 3a), in three cells from patient 2, and in one cell from patient 3. Coamplification of the VH andVL gene rearrangements from single cells was also seen for most B-CLL V region genes. In addition, amplification of the V region genes obtained from single B-CLL cells (and no additional other ones) and also from whole tissue DNA confirmed assignment of these genes to the B-CLL clones. Cells were analyzed with several different primer combinations, as outlined in Table 1.
The efficiency of the amplification of a V region gene from a single cell is usually below 50%,8 and therefore, sometimes two B cells of the CLL were micromanipulated and transferred into a PCR tube to minimize PCR work. We did not sequence 9VH4 and 9 Vλ3gene rearrangements from the B-CLL cells of patient 1, 1Vκ2 gene rearrangement from the B-CLL cells of patient 2, and 1 VH3 gene rearrangement from B-CLL cells of patient 3. The V gene segments used in the rearrangements are given in brackets. Identical V gene designations indicate clonally related V gene rearrangements. In patient 3,1c-1 and 1c-2 represent clonally unrelated rearrangements of the Vλ1 gene1c, amplified from HRS-like and B-CLL cells, respectively (but in both cases repeatedly obtained from the HRS-like and B-CLL cells).
Indicates that one sequence is identical to theVH4 gene rearrangement repeatedly amplified from B-CLL cells.
Indicates that this rearrangement is identical to theVH4 gene rearrangement of the B-CLL cells.
Indicates that one product (VH5-51, in-frame, 19% mutation) was obtained only once. IgD-positive B-cells were analyzed to control the efficiency of the single-cell PCR (data not shown).